These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 6107242

  • 1. The dopamine receptor in the intermediate lobe of the rat pituitary gland: pharmacological characterization.
    Munemura M, Cote TE, Tsuruta K, Eskay RL, Kebabian JW.
    Endocrinology; 1980 Dec; 107(6):1676-83. PubMed ID: 6107242
    [Abstract] [Full Text] [Related]

  • 2. Biochemical identification of the beta-adrenoceptor and evidence for the involvement of an adenosine 3',5'-monophosphate system in the beta-adrenergically induced release of alph-melanocyte-stimulating hormone in the intermediate lobe of the rat pituitary gland.
    Cote T, Munemura M, Eskay RL, Kebabian JW.
    Endocrinology; 1980 Jul; 107(1):108-16. PubMed ID: 6103799
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of a D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland decreases the responsiveness of the beta-adrenoceptor: biochemical mechanism.
    Cote TE, Grewe CW, Kebabian JW.
    Endocrinology; 1981 Feb; 108(2):420-6. PubMed ID: 6256151
    [Abstract] [Full Text] [Related]

  • 4. Evidence that the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland is associated with an inhibitory guanyl nucleotide component.
    Cote TE, Frey EA, Grewe CW, Kebabian JW.
    J Neural Transm Suppl; 1983 Feb; 18():139-47. PubMed ID: 6308147
    [Abstract] [Full Text] [Related]

  • 5. D-2 dopaminergic agonists and adenosine 3',5'-monophosphate directly regulate the synthesis of alpha-melanocyte-stimulating hormone-like peptides by cultured rat melanotrophs.
    Beaulieu M, Felder R, Kebabian JW.
    Endocrinology; 1986 Mar; 118(3):1032-9. PubMed ID: 2419116
    [Abstract] [Full Text] [Related]

  • 6. Release of alpha-melanocyte-stimulating hormone from dispersed cells of the intermediate lobe of the rat pituitary gland: involvement of catecholamines and adenosine 3',5'-monophosphate.
    Munemura M, Eskay RL, Kebabian JW.
    Endocrinology; 1980 Jun; 106(6):1795-803. PubMed ID: 6245851
    [Abstract] [Full Text] [Related]

  • 7. Forskolin stimulates adenylate cyclase activity, adenosine 3',5'-monophosphate production and peptide release from the intermediate lobe of the rat pituitary gland.
    Miyazaki K, Goldman ME, Kebabian JW.
    Endocrinology; 1984 Mar; 114(3):761-6. PubMed ID: 6321138
    [Abstract] [Full Text] [Related]

  • 8. Biochemical and physiological studies of the beta-adrenoceptor and the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland: a review.
    Cote TE, Eskay RL, Frey EA, Grewe CW, Munemura M, Stoof JC, Tsuruta K, Kebabian JW.
    Neuroendocrinology; 1982 Mar; 35(3):217-24. PubMed ID: 6290925
    [Abstract] [Full Text] [Related]

  • 9. Beta 1-adrenergic and dopamine (D1)-receptors coupled to adenylyl cyclase activation in GT1 gonadotropin-releasing hormone neurosecretory cells.
    Findell PR, Wong KH, Jackman JK, Daniels DV.
    Endocrinology; 1993 Feb; 132(2):682-8. PubMed ID: 8093877
    [Abstract] [Full Text] [Related]

  • 10. Characterization of dopamine and beta-adrenergic receptors linked to cyclic AMP formation in intact cells of the clone D384 derived from a human astrocytoma.
    Balmforth AJ, Yasunari K, Vaughan PF, Ball SG.
    J Neurochem; 1988 Nov; 51(5):1510-5. PubMed ID: 2459312
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A, Bockaert J.
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [Abstract] [Full Text] [Related]

  • 12. D-2 dopamine receptor-mediated inhibition of adenylate cyclase activity in the intermediate lobe of the rat pituitary gland requires guanosine 5'-triphosphate.
    Cote TE, Grewe CW, Tsuruta K, Stoof JC, Eskay RL, Kebabian JW.
    Endocrinology; 1982 Mar; 110(3):812-9. PubMed ID: 7056233
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D1 receptor stimulation of cyclic AMP accumulation in COS-1 cells.
    Steffey ME, Snyder GL, Barrett RW, Fink JS, Ackerman M, Adams P, Bhatt R, Gomez E, MacKenzie RG.
    Eur J Pharmacol; 1991 Aug 14; 207(4):311-7. PubMed ID: 1664335
    [Abstract] [Full Text] [Related]

  • 14. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P, Olianas MC, Gessa GL.
    Mol Pharmacol; 1985 Aug 14; 28(2):138-45. PubMed ID: 2410769
    [Abstract] [Full Text] [Related]

  • 15. The activity of substituted benzamides in biochemical models of dopamine receptors.
    Kebabian JW, Tsuruta K, Cote TE, Grewe CW.
    Adv Biochem Psychopharmacol; 1982 Aug 14; 35():17-49. PubMed ID: 6293277
    [No Abstract] [Full Text] [Related]

  • 16. Repartition and drug sensitivity of dopamine and L-isoproterenol-sensitive adenylate cyclases in rat brain homogenates.
    Prémont J, Tassin JP, Thierry AM, Bockaert J.
    Adv Biochem Psychopharmacol; 1976 Aug 14; 15():347-56. PubMed ID: 192054
    [Abstract] [Full Text] [Related]

  • 17. Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis.
    Nisoli E, Tonello C, Memo M, Carruba MO.
    J Pharmacol Exp Ther; 1992 Nov 14; 263(2):823-9. PubMed ID: 1359119
    [Abstract] [Full Text] [Related]

  • 18. [The effects of dopamine on the release of immunoreactive beta-endorphin-like peptide from the dispersed cells of the rat neurointermediate lobe].
    Furuki Y, Munemura M, Sakoda Y, Hatada Y, Maeyama M, Matsumura M.
    Nihon Naibunpi Gakkai Zasshi; 1985 Jul 20; 61(7):744-52. PubMed ID: 2998896
    [Abstract] [Full Text] [Related]

  • 19. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.
    Ryman-Rasmussen JP, Nichols DE, Mailman RB.
    Mol Pharmacol; 2005 Oct 20; 68(4):1039-48. PubMed ID: 15985612
    [Abstract] [Full Text] [Related]

  • 20. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
    Ikeda H, Moribe S, Sato M, Kotani A, Koshikawa N, Cools AR.
    Eur J Pharmacol; 2007 Jan 12; 554(2-3):175-82. PubMed ID: 17113067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.